FDA informed healthcare professionals and patients of the possibility of severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking bisphosphonates.Click here to read the entire alert.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment